|
AFMD
|
Affimed Therapeutics B.V.
|
US
|
NASDAQ
|
|
APTO
|
Aptose Biosciences, Inc.
|
US
|
NASDAQ
|
|
ARAV
|
Aravive, Inc.
|
US
|
NASDAQ
|
|
CLLS
|
Cellectis S.A.
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HOWL
|
Werewolf Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IDRA
|
Idera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
INCY
|
Incyte Corporation
|
US
|
NASDAQ
|
|
INFI
|
Infinity Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
INMB
|
INmune Bio Inc.
|
US
|
NASDAQ
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PRTC
|
PureTech Health plc
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
US
|
NASDAQ
|
|
SLS
|
SELLAS Life Sciences Group, Inc.
|
US
|
NASDAQ
|
|
TCRX
|
TScan Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CMVLF
|
Cellectis Romainvil
|
US
|
OTC
|
|
JNJ
|
Johnson & Johnson Co DRC
|
AR
|
BA
|
|
JNJ
|
Johnson & Johnson
|
DE
|
F
|
|
2616
|
CStone Pharmaceuticals
|
HK
|
HK
|